JPRN-UMIN000011019
Recruiting
未知
Orencia Clinical study in Early rheumatoid Arthritis using New criteria(Efficacy and safety of MTX therapy and Abatacept/MTX combination therapy in early RA patients in daily clinical practice retrospective observation study.) - OCEAN study
ConditionsRheumatoid Arthritis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Rheumatoid Arthritis
- Sponsor
- School of Medicine, Keio University
- Enrollment
- 75
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who are inadequate by investigator's decision.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Remission Induction in Very Early Rheumatoid Arthritis (RIVERA):a comparison of etanercept plus methotrexate plus steroid with standard therapy - RIVERAEUCTR2006-001428-38-GBniversity Hospitals Birmingham NHS Foundation Trust20
Completed
Not Applicable
Remission Induction in Very Early Rheumatoid Arthritis: a comparison of etanercept plus methotrexate plus steroid with standard therapyISRCTN49682259Record Provided by the NHSTCT Register - 2007 Update - Department of Health20
Not yet recruiting
Phase 4
Remission Induction of Very Early Rheumatoid Arthritis with Methotrexate and Etanerceptrheumatoid arthritisJPRN-C000000452Johoku Biological Summit50
Completed
Not Applicable
Rheumatoid Arthritis with Orencia Trial Toward Sjogren's syndrome Endocrinopathy (ROSE II Trial)JPRN-UMIN000016273Department of Internal Medicine, Faculty of Medicine, University of Tsukuba68
Recruiting
Phase 2
Rheumatoid Arthritis with Orencia Trial Toward Sjogren's syndrome endocrinopathy (ROSE Trial)rheumatoid arthritis complicated by sjogren's syndromeJPRN-UMIN000005724Division of Clinical Immunology, Major of Advanced Biochemical Applications, Graduate School of Comprehensive Human Science,University of Tsukuba Takayuki Sumida30